Related Experiment Video
Updated: Feb 27, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
5.3K
Effect of the Support, Educate, Empower Personalized Glaucoma Coaching Program on Medication Adherence: The SEE
Paula Anne Newman-Casey1, Leslie M Niziol1, Ming-Chen Lu1
1Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor.
JAMA Ophthalmology
|February 26, 2026
Summary
The Support, Educate, Empower (SEE) intervention significantly improved glaucoma medication adherence and reduced patient distress compared to standard education. This coaching program offers an evidence-based approach to enhance adherence and improve glaucoma outcomes.
Area of Science:
- Ophthalmology
- Public Health
- Behavioral Science
Background:
- Medication nonadherence is a primary cause of vision loss in glaucoma patients.
- Improving adherence can enhance patient outcomes and reduce healthcare burdens.
Purpose of the Study:
- To compare the efficacy of the Support, Educate, Empower (SEE) intervention against standard written education for improving glaucoma medication adherence.
Main Methods:
- A 1:1 randomized clinical trial involving adults with glaucoma and low self-reported adherence.
- The SEE intervention included motivational interviewing, health coaching, and automated reminders over 6 months.
- Medication adherence was electronically monitored; glaucoma-related distress was a secondary outcome.
Main Results:
- The SEE intervention group showed significantly better medication adherence (77.6%) compared to the control group (58.0%).
- A higher proportion of participants in the SEE group achieved 80% adherence (54.9% vs 23.7%).
- The SEE intervention also led to a significant reduction in glaucoma-related distress.
Conclusions:
- The Support, Educate, Empower (SEE) program effectively improves medication adherence in glaucoma patients.
- This intervention represents a viable, evidence-based strategy to enhance adherence and potentially improve long-term glaucoma management and outcomes.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
01:28Angle Closure Glaucoma: Treatment
1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K
01:25Glaucoma: Overview
1.5K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.5K
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
764
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
764
01:11Blinding
4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
01:23Ophthalmic Drug Delivery Systems
97
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
97